Claire Torchet,
,
Christine Allmang,
Tracey Shipman, and
David Tollervey*
Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom
Received 11 March 2005/ Returned for modification 27 April 2005/ Accepted 10 August 2005
| ABSTRACT |
|---|
|
|
|---|
. This may indicate that the major function of Rrp6p is in RNA surveillance. Inactivation of core exosome components, Rrp41p and Mtr3p, or the nuclear RNA helicase Mtr4p gave different phenotypes, with accumulation of deadenylated and 3'-truncated mRNAs. We speculate that slowed mRNA polyadenylation in the pap1-5 strain is detected by a surveillance activity of Rrp6p, triggering rapid deadenylation and exosome-mediated degradation. In wild-type strains, assembly of the cleavage and polyadenylation complex might be suboptimal at cryptic polyadenylation sites, causing slowed polyadenylation. | INTRODUCTION |
|---|
|
|
|---|
Ski7p functions together with the core exosome in cytoplasmic mRNA turnover and RNA surveillance pathways (3, 49). In contrast, the functions of Rrp6p and Lrp1p/Rrp47p are distinct from those of the core components of the exosome during nuclear 3' processing of several small stable RNAs, including the 5.8S rRNA (1, 2, 9, 30, 35, 47). In these cases, Rrp6p specifically processes RNA intermediates that are generated by the activity of the core exosome.
In eukaryotic mRNAs, the 3' poly(A) tail plays key roles in translation, mRNA stability, and, at least in some cases, nuclear export. The poly(A) tail is added to the 3' ends of mRNAs by poly(A) polymerase, Pap1p in yeast (34), within a large processing complex in a reaction that is normally coupled to cotranscriptional mRNA cleavage and transcription termination (6, 53; reviewed in references 27 and 37). In some strains with defects in pre-mRNA cleavage, long 3'-extended transcripts that are rapidly degraded by the nuclear exosome are generated (42). In certain cases, subsequent polyadenylation that is uncoupled to pre-mRNA cleavage can apparently generate functional mRNAs from pre-mRNAs that have been 3' processed by the exosome. Rrp6p is not required for the initial processing of the 3'-extended transcripts (42). However, in strains defective in mRNA cleavage due to the rna14-1 mutation (28, 29), Rrp6p plays a distinct role in pre-mRNA degradation following initial processing by the exosome, apparently antagonizing polyadenylation. However, recombinant Rrp6p was reported to show no preference for poly(A)+ RNAs in vitro (11), so any direct role in deadenylation is unlikely to result from the intrinsic specificity of the Rrp6p exonuclease activity. A different role for RNA polyadenylation in stimulating nuclear RNA degradation by the exosome has been described recently (21, 22, 50, 52). This involves a distinct nuclear poly(A) polymerase, Trf4p (22, 39, 50, 52).
A previous analysis identified the rrp6-1 point mutation, which alters a key residue in the catalytic region of Rrp6p, as a suppressor of the temperature-sensitive (TS) lethal mutation pap1-1 (9, 11, 34, 36). This suggested that Rrp6p, and perhaps the nuclear exosome, plays a role in degrading mRNAs that have failed to undergo polyadenylation. Consistent with this model, Rrp6p was required to restrict mRNAs synthesized in pap1-1 strains to a nuclear region that was proposed to lie close to the site of transcription (18).
To better define the role of the exosome in the degradation of mRNAs with defects in polyadenylation, we examined poly(A) tail length and mRNA degradation in strains carrying a collection of reported TS lethal alleles of PAP1 (28). In each mutant, mRNA levels were rapidly reduced after transfer to nonpermissive temperature. However, in pap1-5, but not pap1-2, strains, the reduced level of residual mRNAs appeared to be substantially polyadenylated at the nonpermissive temperature. Further analyses led to the conclusion that the deficiency in mRNAs in the pap1-5 strain is not due to the inability to synthesize poly(A) tails per se but to an RNA surveillance pathway that triggers nuclear deadenylation and exosome-mediated degradation of the newly synthesized pre-mRNAs.
| MATERIALS AND METHODS |
|---|
|
|
|---|
), the RRP6 open reading frame was replaced by Kluyveromyces lactis URA3 in strain pap1-5 by using primers 5'RRP6::URA (849) (see Table S2 in the supplemental material for the sequence) and 3'RRP6::URA (850). Transformants were selected for Ura+ prototrophy and analyzed by Northern blotting for 5.8S rRNA processing defects. To make strains YCT56 (pap1-5/GAL::rrp41) and YCT59 (pap1-5/rrp6
/GAL::rrp41), the HIS3-GAL10-ProtA-RRP41 cassette was amplified by PCR from strain P118 with primers RRP41-1 (842) and RRP41-2 (843) and transformed into strains pap1-5 and YCA42. Correct gene deletion was confirmed by analysis of the 5.8S rRNA processing defect. Strain YCT83 (pap1-5/mtr3-1) was obtained by sporulation of diploids resulting from crossing pap1-5 with YCT73. The KAN-GAL-3HA-MTR4 construct was generated from strain YCBA81 by one-step PCR (22a) in strain pap1-5 with primers MTR4-F4 (991) and MTR4-R3 (992). Transformants were selected for kanamycin resistance and analyzed by Northern blotting for 5.8S rRNA processing defects. One transformant, YCT109 (pap1-5/GAL::MTR4), was selected. To make strains YCT68 (ski7
) and YCT71 (pap1-5/ski7
), the KAN::ski7 cassette was amplified by PCR from strain Y01852 (EUROSCARF) with primers SKI7-1 (993) and SKI7-2 (994) and transformed into D270 and pap1-5, respectively. Correct integration was confirmed by PCR. To make strains YLM122 (ccr4
) and YLM124 (pap1-5/ccr4
), the KAN::ccr4 cassette was amplified by PCR from strain Y00387 (EUROSCARF) with primers CCR4-1 (1101) and CCR4-2 (1102) and transformed into D270 and pap1-5, respectively; correct integration was confirmed by PCR. To make strains YLM127 (pan2
) and YLM129 (pap1-5/pan2
), the KAN::pan2 cassette was amplified by PCR from strain Y04461 (EUROSCARF) with primers PAN2-1 (1104) and PAN2-2 (1105) and transformed into D270 and pap1-5, respectively; correct integration was confirmed by PCR. Strain YLM121 (pap1-5/rrp6-1) was obtained by sporulation of diploids resulting from crossing pap1-5 with a strain carrying the rrp6-1 allele (11). RNA extraction and analysis. RNA extractions were performed as described previously (41). Seven micrograms of total RNA was analyzed for each sample. Small RNAs were separated on a 6% acrylamide gel containing 8.3 M urea and transferred to a Hybond N+ membrane by electrotransfer. High-molecular-weight RNAs were analyzed on 1.2% agarose gels and transferred by capillary elution. For the oligonucleotides used, see Table S2 in the supplemental material.
For poly(A) tail length analysis of mRNA, 7 µg of total RNA was digested with 10 µg of RNase A and 250 units of RNase T1 in 10 mM Tris, pH 8, 300 mM NaCl. The digestion was stopped by adding 10 mM EDTA, 0.25% sodium dodecyl sulfate, 25 µg/ml proteinase K, and 0.5 mg/ml glycogen. Samples were precipitated, and then 3' end labeling of the poly(A) tails was carried out overnight at 4°C with 10 µCi [32P]pCp (cytidine-3',5'-bisphosphate) and 40 units of T4 RNA ligase in 50 mM Tris-HCl, pH 7.9, 10 mM MgCl2, 3.3 mM dithiothreitol, 10 µg/ml bovine serum albumin, and 10% dimethyl sulfoxide. Samples were then phenol-chloroform extracted and precipitated, and electrophoretic separation was analyzed on a 12% acrylamide-8 M urea gel. For total poly(A) tail analysis, 7 µg of total RNA was extensively hydrolyzed with RNase A and RNase T1. Following ethanol precipitation to remove free nucleotides, residual poly(A) tracts were 3' end labeled with [32P]pCp and RNA ligase and resolved on a 12% polyacrylamide gel containing 8 M urea. Similar results were obtained with two independent experiments.
RNase H treatment. Deadenylation was performed essentially as described previously (33). Samples (20 µg) of RNA were annealed with 400 ng oligo(dT) at 68°C for 10 min and digested with 1.5 U RNase H at 30°C for 1 h.
| RESULTS |
|---|
|
|
|---|
|
strain relative to the pap1-5 single mutant. In contrast, no increases were seen in the pap1-2 rrp6
strain relative to pap1-2 alone. Quantification is shown for CYH2 transcript and is standardized relative to scR1 RNA, a component of the cytoplasmic signal recognition particle. These observations suggested a role for the nuclear exosome in the degradation of newly synthesized poly(A)+ pre-mRNAs in the pap1-5 mutant strain. To confirm the nuclear localization of this degradation, the pap1-5 allele was also combined with a deletion of the gene encoding the cytoplasmic exosome component Ski7p, which is required for 3' degradation of cytoplasmic mRNAs (3, 5, 45, 49). No clear mRNA stabilization was conferred by the absence of Ski7p, and no truncated RNA species were observed (Fig. 1C).
The loss of mRNA from the pap1-5 strain was assessed during a time course following transfer to 37°C. Several mRNAs tested (ACT1, CYH2, RPL25, and MFA2 and RPL30, RPS26a, and CYC1) (Fig. 2A and B, lanes 8 to 14, and data not shown) were all progressively depleted at 37°C in the pap1-5 strain, indicating that accumulation of new mRNA was inhibited. However, even at late time points, residual mRNAs were present in the pap1-5 strain, indicating a reduced level of ongoing mRNA synthesis. Quantification is shown for the CYH2 transcript, standardized to scR1 RNA.
|
strain (Fig. 2A and B, lanes 15 to 21). For all mRNAs tested, synthesis in the pap1-5 strain at 37°C was substantially increased by the absence of Rrp6p. The rrp6
mutation alone did not strongly affect these mRNA species (data not shown). The pap1-5 mutation was also combined with GAL::RRP41 to allow depletion of the core exosome component Rrp41p. In pap-1-5 strains depleted of Rrp41p, a substantially different phenotype was observed (Fig. 2A and B, lanes 22 to 29). For most mRNAs tested, truncated RNA species were observed that migrated at positions below the size range of mRNAs in the wild type. Such truncated RNAs are not seen in strains lacking only Rrp41p (data not shown; see references 8 and 42), showing that they are a consequence of some defect in mRNA synthesis in the pap1-5 strain. An exception was the ACT1 (actin) mRNA, for which truncated RNAs were not detected by Northern hybridization of the full-length mRNA but were observed following truncation by RNase H cleavage (data not shown). A 3'-extended RNA species was visible in strains lacking Rrp41p. This RNA was also detected with a probe to the ACT1 3' flanking sequence (data not shown). An increased level of this RNA species was previously observed in the pap1-1 strain (26).
In the pap1-5 GAL::RRP41 strain, very rapid loss of many mRNAs was seen after transfer to 37°C. This effect was not dependent on the pap1-5 mutation and was also seen in PAP1+ strains depleted of core exosome components (data not shown) or the exosome cofactor Mtr4p (see Fig. 4). In some preparations, a substantial decline in mRNA levels was also seen in wild-type strains. The mechanism underlying these precipitous reductions in cytoplasmic mRNA levels is still unclear. The mRNAs detected at later time points are presumably synthesized de novo at the nonpermissive temperature, confirming the continued synthesis of poly(A)+ RNAs.
|
These results indicated that the exosome components Rrp6p and Rrp41p play distinct roles during mRNA degradation in the pap1-5 strain. To determine whether Rrp6p acts prior to Rrp41p and the core exosome, we constructed a pap1-5 strain that lacked Rrp6p and could be depleted of Rrp41p (Fig. 2A and B, lanes 30 to 37, and Fig. 2C, lanes 25 to 30). The absence of Rrp6p suppressed accumulation of the truncated RNA species, which were seen in the pap1-5 strain depleted of Rrp41p alone, for most mRNAs tested, CYH2 and SSA3 (Fig. 2A to C) and CYC1 and RPL30 (data not shown). In the experiment shown in Fig. 2, the absence of Rrp6p plus Rrp41p from pap1-5 had little effect on the RPL25 mRNAs relative to depletion of Rrp41p alone (Fig. 2B). However, loss of the truncated RPL25 species was evident in other experiments; the reason for this variability is still unclear.
It is notable that the reduction in mRNA levels in pap1-5 mutant strains, and the degree of restoration in rrp6
mutants, showed substantial variation for different mRNA species. Heterogeneity has been seen in the nuclear degradation of unspliced pre-mRNAs (8). As in the cytoplasm, mRNA degradation in the nucleus apparently proceeds at species-specific rates and shows variations in response to mutations in the degradation machinery. This presumably reflects differences in RNP structure.
mRNAs present in the pap1-5 strain at nonpermissive temperature are polyadenylated.
To assess the polyadenylation states of mRNAs present in the pap1-5 strains at 37°C, deadenylation was performed in vitro using RNase H and oligo(dT) (Fig. 3A; quantification is shown for the RPL25 and RPL30 transcripts in Fig. 3B). Deadenylation of the wild-type samples resulted in increased in-gel mobility and more coherent RNA distribution for the RPL25, RPL30, and MFA2 mRNAs, as expected. This was also the case for RNA in the pap1-5 rrp6
strain at nonpermissive temperature, confirming that polyadenylated mRNAs continue to be synthesized. In the pap1-5 single mutant, residual RPL30 and MFA2 were still polyadenylated at the nonpermissive temperature, but this was less clear for RPL25. The pap1-5 strain depleted of Rrp41p showed little accumulation of poly(A)+ RNA relative to the pap1-5 single mutant but accumulated deadenylated and truncated species (Fig. 3A).
|
We conclude that in the pap1-5 strain these mRNAs largely undergo Rrp6p-dependent deadenylation followed by Rrp41p-dependent degradation. This suggests that the drastic reductions in mRNA levels seen in the pap1-5 strain following transfer to 37°C are not primarily due to an inability to synthesize poly(A)+ mRNAs. Rather, the newly synthesized mRNAs are rapidly identified by an RNA surveillance mechanism that requires Rrp6p.
Degradation following deadenylation requires Mtr3p and Mtr4p. To confirm that the phenotypes seen on depletion of Rrp41p were due to defects in the function of the nuclear exosome, the pap1-5 allele was combined with a TS lethal mutation in the core exosome component Mtr3p and with the GAL::MTR4 allele, which allows genetic depletion of Mtr4p/Dob1p (15), a putative RNA helicase and cofactor for the nuclear exosome (Fig. 4). In the pap1-5 mtr3-1 double-mutant strain, loss of the polyadenylated mRNA after transfer to 37°C was accompanied by accumulation of deadenylated and truncated mRNAs (Fig. 4, lanes 22 to 28). Quantification is shown for the CYH2 mRNA and is standardized relative to scR1 RNA.
In the Mtr4p-depleted strains, the RPL30 and RPL25 mRNAs were very rapidly lost following transfer to 37°C. In the pap1-5 strain depleted of Mtr4p, the appearance of de novo-synthesized mRNAs that were deadenylated and truncated was seen at later time points (Fig. 4, lanes 37 to 44). This phenotype closely resembles that seen in the pap1-5 strain depleted of Rrp41p (Fig. 2).
We conclude that in pap1-5 strains newly synthesized poly(A)+ mRNAs are rapidly deadenylated, followed by 3'
5' degradation by the nuclear exosome, acting together with its cofactor Mtr4p.
Deadenylation does not require the catalytic activity of Rrp6p.
In vitro analyses have shown that the residue altered in the rp6-1 allele is critically required for catalysis, and the mutant protein is therefore unlikely to show exonuclease activity in vivo (11, 36). To determine whether Rrp6p is directly responsible for mRNA deadenylation in the pap1-5 strain, a pap1-5 rrp6-1 strain was constructed. The levels of the RPL30 and RPS26a mRNAs were mildly elevated in the pap1-5 rrp6-1 strain relative to pap1-5 alone, but rrp6-1 had much less effect than rrp6
(Fig. 5A and B) and other mRNAs. The exonuclease activity of Rrp6p may participate in deadenylation but is apparently not required for degradation to occur.
|
single-mutant strain is impaired in growth, but despite this, the rrp6
pap1-5 strain clearly grew better than the pap1-5 single mutant. In contrast, growth of the rrp6-1 pap1-5 strain was indistinguishable from that of the strain with pap1-5 alone, consistent with the low level of suppression seen in Northern analyses. These results suggest that Rrp6p has an RNA surveillance function that is distinct from its exonuclease activities and is required to identify mRNAs synthesized in the pap1-5 strain as being defective and to target them for degradation.
|
and pan2
mutations were each combined with pap1-5. Neither mutation conferred significant mRNA stabilization in the pap1-5 strain (see Fig. S2 and S3 in the supplemental material). Consistent with this, neither double mutant showed increased growth in liquid culture relative to pap1-5 alone (data not shown). The combination of pan2
with rrp6
and pap1-5 in a triple-mutant strain failed to increase mRNA synthesis or growth relative to the rrp6
pap1-5 double mutant (data not shown; see Fig. S2 in the supplemental material). | DISCUSSION |
|---|
|
|
|---|
|
for defects in stable RNA synthesis (9, 11, 36). However, the presence of the rrp6-1 mutation conferred little suppression of mRNA synthesis in pap1-5 strains and did not lead to detectable accumulation of degradation intermediates. Moreover, unlike rrp6
, the rrp6-1 mutation conferred no growth suppression in pap1-5 strains. This indicates that while Rrp6p is required for surveillance of the mRNAs synthesized in the pap1-5 strain, its exonuclease activity is not required for their degradation. Rrp6p is comprised of two distinct domains, with an amino-terminal exonuclease domain and a C-terminal HRDC (helicase and RNase D C-terminal) domain. The HRDC domain has been proposed to play a regulatory role in Rrp6p function (36) and is likely to have nucleic acid binding activity (20). It is therefore possible that the HRDC domain specifically functions in surveillance in the pap1-5 strain. Since Rrp6p is apparently not required for mRNA deadenylation, we tested two other characterized yeast deadenylases, Ccr4p and Pan2p (7, 10, 44). However, the decline in the levels of most mRNAs tested following transfer to 37°C was indistinguishable in pap1-5 strains and pap1-5 ccr4
or pap1-5 pan2
double mutants. Moreover, mRNA levels in the pap1-5 rrp6
pan2
triple mutant were not different from those in the pap1-5 rrp6
double-mutant strain. Consistent with this observation, pan2
also conferred no growth increase in the pap1-5 strain. This indicates that Ccr4p and Pan2p are not individually responsible for nuclear deadenylation in the pap1-5 background. It may be that once an mRNA has been targeted for degradation in an Rrp6p-dependent process, multiple proteins can participate in the deadenylation. During 3' maturation of the yeast 5.8S rRNA, several 3' exonucleases participate in the final trimming (9, 31, 46), and this is also the case for many RNA-processing and degradation steps in bacteria (24).
The features that make nuclear pre-mRNAs targets for degradation in pap1-5 strains have not yet been established. Candidates for features that might be recognized include defects in the structure of the cleavage and polyadenylation machinery, the presence of shortened poly(A) tails, and a reduced rate of polyadenylation. We favor the last possibility and speculate that assembly of the cleavage and polyadenylation machinery at suboptimal, and therefore potentially inappropriate, sites may be correlated with a lower rate of poly(A) addition and/or reduced processivity of the reaction. The low sequence complexity of polyadenylation sites suggests that many potential cryptic sites exist. Glutathione S-transferase-tagged Rrp6p has been reported to coprecipitate with Pap1p from cell lysates (11), indicating that they can physically interact. It is conceivable that prolonged association of Pap1p with the pre-mRNA, due to slowed polyadenylation, might be sufficient to recruit Rrp6p and the exosome.
In multicellular organisms, regulated and alternative poly(A) site choice has been reported and can have important developmental consequences (4, 13, 16, 23, 40). In such cases, the nuclear RNA surveillance pathway we report here may be important in determining the relative levels of the mRNAs synthesized.
| ACKNOWLEDGMENTS |
|---|
C.T. was the recipient of a fellowship from FEBS. This work was supported by the Wellcome Trust and EU grant QLG2-CT-2001-01554.
| FOOTNOTES |
|---|
¶ Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
These authors contributed equally to the work. ![]()
Present address: Unité de Génétique des Interactions Macromoléculaires, URA 2171-CNRS, Institut Pasteur, 25-28 rue du Docteur ROUX, F-75724 Paris Cedex 15, France. ![]()
Present address: UPR 9002 du CNRS, Institut de Biologie Moleculaire et Cellulaire, 15 rue Rene Descartes, F-67084 Strasbourg Cedex, France. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Allmang, C., E. Petfalski, A. Podtelejnikov, M. Mann, D. Tollervey, and P. Mitchell. 1999. The yeast exosome and human PM-Scl are related complexes of 3'
5' exonucleases. Genes Dev. 13:2148-2158.
3. Araki, Y., S. Takahashi, T. Kobayashi, H. Kajiho, S. Hoshino, and T. Katada. 2001. Ski7p G protein interacts with the exosome and the Ski complex for 3'-to-5' mRNA decay in yeast. EMBO J. 20:4684-4693.[CrossRef][Medline]
4. Audibert, A., and M. Simonelig. 1998. Autoregulation at the level of mRNA 3' end formation of the suppressor of forked gene of Drosophila melanogaster is conserved in Drosophila virilis. Proc. Natl. Acad. Sci. USA 95:14302-14307.
5. Benard, L., K. Carroll, R. C. P. Valle, D. C. Masison, and R. B. Wickner. 1999. The ski7 antiviral protein is an EF1-alpha homolog that blocks expression of non-poly(A) mRNA in Saccharomyces cerevisiae. J. Virol. 73:2893-2900.
6. Birse, C. E., L. Minvielle-Sebastia, B. A. Lee, W. Keller, and N. J. Proudfoot. 1998. Coupling termination of transcription to messenger RNA maturation in yeast. Science 280:298-301.
7. Boeck, R., S. J. Tarun, M. Rieger, J. A. Deardorff, S. Müller-Auer, and A. B. Sachs. 1996. The yeast Pan2 protein is required for poly(A)-binding protein-stimulated poly(A)-nuclease activity. J. Biol. Chem. 271:432-438.
8. Bousquet-Antonelli, C., C. Presutti, and D. Tollervey. 2000. Identification of a regulated pathway for nuclear pre-mRNA turnover. Cell 102:765-775.[CrossRef][Medline]
9. Briggs, M. W., K. T. Burkard, and J. S. Butler. 1998. Rrp6p, the yeast homologue of the human PM-Scl 100-kDa autoantigen, is essential for efficient 5.8 S rRNA 3' end formation. J. Biol. Chem. 273:13255-13263.
10. Brown, C. E., S. Z. Tarun, Jr., R. Boeck, and A. B. Sachs. 1996. PAN3 encodes a subunit of the Pab1p-dependent poly(A) nuclease in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:5744-5753.[Abstract]
11. Burkard, K. T., and J. S. Butler. 2000. A nuclear 3'-5' exonuclease involved in mRNA degradation interacts with poly(A) polymerase and the hnRNA protein Npl3p. Mol. Cell. Biol. 20:604-616.
12. Butler, S. 2002. The ying and yang of the exosome. Trends Biochem. Sci. 12:90-96.[CrossRef]
13. Castelo-Branco, P., A. Furger, M. Wollerton, C. Smith, A. Moreira, and N. Proudfoot. 2004. Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol. Cell. Biol. 24:4174-4183.
14. Daugeron, M. C., F. Mauxion, and B. Seraphin. 2001. The yeast POP2 gene encodes a nuclease involved in mRNA deadenylation. Nucleic Acids Res. 29:2448-2455.
15. de la Cruz, J., D. Kressler, D. Tollervey, and P. Linder. 1998. Dob1p (Mtr4p) is a putative ATP-dependent RNA helicase required for the 3' end formation of 5.8S rRNA in Saccharomyces cerevisiae. EMBO J. 17:1128-1140.[CrossRef][Medline]
16. Edwalds-Gilbert, G., K. L. Veraldi, and C. Milcarek. 1997. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res. 25:2547-2561.
17. Gietz, R. D., R. H. Schiestl, A. R. Willems, and R. A. Woods. 1995. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11:355-360.[CrossRef][Medline]
18. Hilleren, P., T. McCarthy, M. Rosbash, R. Parker, and T. H. Jensen. 2001. Quality control of mRNA 3'-end processing is linked to the nuclear exosome. Nature 413:538-542.[CrossRef][Medline]
19. Hirose, Y., and J. L. Manley. 2000. RNA polymerase II and the integration of nuclear events. Genes Dev. 14:1415-1429.
20. Janscak, P., P. L. Garcia, F. Hamburger, Y. Makuta, K. Shiraishi, Y. Imai, H. Ikeda, and T. A. Bickle. 2003. Characterization and mutational analysis of the RecQ core of the bloom syndrome protein. J. Mol. Biol. 330:29-42.[CrossRef][Medline]
21. Kadaba, S., A. Krueger, T. Trice, A. M. Krecic, A. G. Hinnebusch, and J. Anderson. 2004. Nuclear surveillance and degradation of hypomodified initiator tRNAMet in S. cerevisiae. Genes Dev. 18:1227-1240.
22. LaCava, J., J. Houseley, C. Saveanu, E. Petfalski, E. Thompson, A. Jacquier, and D. Tollervey. 2005. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell 121:713-724.[CrossRef][Medline]
22. LaFontaine, D., and D. Tollervey. 1996. One-step PCR mediated strategy for the construction of conditionally expressed and epitope tagged yeast proteins. Nucleic Acids Res. 24:3469-3472.
23. Legendre, M., and D. Gautheret. 2003. Sequence determinants in human polyadenylation site selection. BMC Genomics 4:7.[CrossRef][Medline]
24. Li, Z., S. Pandit, and M. P. Deutscher. 1998. 3' Exoribonucleolytic trimming is a common feature of the maturation of small, stable RNAs in Escherichia coli. Proc. Natl. Acad. Sci. USA 95:2856-2861.
25. Lorentzen, E., P. Walter, S. Fribourg, E. Evguenieva-Hackenberg, G. Klug, and E. Conti. 2005. The archaeal exosome core is a hexameric ring structure with three catalytic subunits. Nat. Struct. Mol. Biol. 12:575-581.[CrossRef][Medline]
26. Mandart, E., and R. Parker. 1995. Effects of mutations in the Saccharomyces cerevisiae RNA14, RNA15, and PAP1 genes on polyadenylation in vivo. Mol. Cell. Biol. 15:6979-6986.[Abstract]
27. Minvielle-Sebastia, L., and W. Keller. 1999. mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. Curr. Opin. Cell Biol. 11:352-357.[CrossRef][Medline]
28. Minvielle-Sebastia, L., P. J. Preker, and W. Keller. 1994. RNA14 and RNA15 proteins as components of a yeast pre-mRNA 3'-end processing factor. Science 266:1702-1705.
29. Minvielle-Sebastia, L., B. Winsor, N. Bonneaud, and F. Lacroute. 1991. Mutations in the yeast RNA14 and RNA15 genes result in an abnormal mRNA decay rate; sequence analysis reveals an RNA-binding domain in the RNA15 protein. Mol. Cell. Biol. 11:3075-3087.
30. Mitchell, P., E. Petfalski, R. Houalla, A. Podtelejnikov, M. Mann, and D. Tollervey. 2003. Rrp47p is an exosome-associated protein required for the 3' processing of stable RNAs. Mol. Cell. Biol. 23:6982-6992.
31. Mitchell, P., E. Petfalski, A. Shevchenko, M. Mann, and D. Tollervey. 1997. The exosome; a conserved eukaryotic RNA processing complex containing multiple 3'
5' exoribonuclease activities. Cell 91:457-466.[CrossRef][Medline]
32. Mitchell, P., and D. Tollervey. 2000. Musing on the structural organization of the exosome complex. Nat. Struct. Biol. 7:843-846.[CrossRef][Medline]
33. Muhlrad, D., and R. Parker. 1992. Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev. 6:2100-2111.
34. Patel, D., and J. S. Butler. 1992. Conditional defect in mRNA 3' end processing caused by a mutation in the gene for poly(A) polymerase. Mol. Cell. Biol. 12:3297-3304.
35. Peng, W. T., M. D. Robinson, S. Mnaimneh, N. J. Krogan, G. Cagney, Q. Morris, A. P. Davierwala, J. Grigull, X. Yang, W. Zhang, N. Mitsakakis, O. W. Ryan, N. Datta, V. Jojic, C. Pal, V. Canadien, D. Richards, B. Beattie, L. F. Wu, S. J. Altschuler, S. Roweis, B. J. Frey, A. Emili, J. F. Greenblatt, and T. R. Hughes. 2003. A panoramic view of yeast noncoding RNA processing. Cell 113:919-933.[CrossRef][Medline]
36. Phillips, S., and J. S. Butler. 2003. Contribution of domain structure to the RNA 3' end processing and degradation functions of the nuclear exosome subunit Rrp6p. RNA 9:1098-1107.
37. Proudfoot, N. 2000. Connecting transcription to messenger RNA processing. Trends Biochem. Sci. 25:290-293.[CrossRef][Medline]
38. Proudfoot, N. J., A. Furger, and M. J. Dye. 2002. Integrating mRNA processing with transcription. Cell 108:501-512.[CrossRef][Medline]
39. Saitoh, S., A. Chabes, W. H. McDonald, L. Thelander, J. R. Yates, and P. Russell. 2002. Cid13 is a cytoplasmic poly(A) polymerase that regulates ribonucleotide reductase mRNA. Cell 109:563-573.[CrossRef][Medline]
40. Simpson, G. G., P. P. Dijkwel, V. Quesada, I. Henderson, and C. Dean. 2003. FY is an RNA 3' end-processing factor that interacts with FCA to control the Arabidopsis floral transition. Cell 113:777-787.[CrossRef][Medline]
41. Tollervey, D., and I. W. Mattaj. 1987. Fungal small nuclear ribonucleoproteins share properties with plant and vertebrate U-snRNPs. EMBO J. 6:469-476.[Medline]
42. Torchet, C., C. Bousquet-Antonelli, L. Milligan, E. Thompson, J. Kufel, and D. Tollervey. 2002. Processing of 3' extended read-through transcripts by the exosome can generate functional mRNAs. Mol. Cell 9:1285-1296.[CrossRef][Medline]
43. Tucker, M., R. R. Staples, M. A. Valencia-Sanchez, D. Muhlrad, and R. Parker. 2002. Ccr4p is the catalytic subunit of a Ccr4p/Pop2p/Notp mRNA deadenylase complex in Saccharomyces cerevisiae. EMBO J. 21:1427-1436.[CrossRef][Medline]
44. Tucker, M., M. A. Valencia-Sanchez, R. R. Staples, J. Chen, C. L. Denis, and R. Parker. 2001. The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell 104:377-386.[CrossRef][Medline]
45. van Hoof, A., P. A. Frischmeyer, H. C. Dietz, and R. Parker. 2002. Exosome-mediated recognition and degradation of mRNAs lacking a termination codon. Science 295:2262-2264.
46. van Hoof, A., P. Lennertz, and R. Parker. 2000. Three conserved members of the RNase D family have unique and overlapping functions in the processing of 5S, 5.8S, U4, U5, RNase MRP and RNase P RNAs in yeast. EMBO J. 19:1357-1365.[CrossRef][Medline]
47. van Hoof, A., P. Lennertz, and R. Parker. 2000. Yeast exosome mutants accumulate 3'-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs. Mol. Cell. Biol. 20:441-452.
48. van Hoof, A., and R. Parker. 1999. The exosome: a proteasome for RNA? Cell 99:347-350.[CrossRef][Medline]
49. van Hoof, A., R. R. Staples, R. E. Baker, and R. Parker. 2000. Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol. Cell. Biol. 20:8230-8243.
50. Vanacova, S., J. Wolf, G. Martin, D. Blank, S. Dettwiler, A. Friedlein, H. Langen, G. Keith, and W. Keller. 2005. A new yeast poly(A) polymerase complex involved in RNA quality control. PLoS Biol. 3:e189.[CrossRef][Medline]
52. Wyers, F., M. Rougemaille, G. Badis, J.-C. Rousselle, M.-E. Dufour, J. Boulay, B. Régnault, F. Devaux, A. Namane, B. Séraphin, D. Libri, and A. Jacquier. 2005. Cryptic Pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase. Cell 121:725-737.[CrossRef][Medline]
53. Yonaha, M., and N. J. Proudfoot. 2000. Transcriptional termination and coupled polyadenylation in vitro. EMBO J. 19:3770-3777.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|